Semiconductors
Compare Stocks
2 / 10Stock Comparison
ICHR vs AZTA
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
ICHR vs AZTA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Semiconductors | Medical - Instruments & Supplies |
| Market Cap | $2.35B | $1.13B |
| Revenue (TTM) | $959M | $595M |
| Net Income (TTM) | $-51M | $-62M |
| Gross Margin | 11.3% | 44.6% |
| Operating Margin | -3.8% | -3.2% |
| Forward P/E | 59.2x | 31.4x |
| Total Debt | $186M | $51M |
| Cash & Equiv. | $98M | $280M |
ICHR vs AZTA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Ichor Holdings, Ltd. (ICHR) | 100 | 297.9 | +197.9% |
| Azenta, Inc. (AZTA) | 100 | 61.6 | -38.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ICHR vs AZTA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ICHR has the current edge in this matchup, primarily because of its strength in income & stability and growth exposure.
- Dividend streak 1 yrs, beta 3.93
- Rev growth 11.6%, EPS growth -140.6%, 3Y rev CAGR -9.5%
- 5.9% 10Y total return vs AZTA's 185.4%
AZTA is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 2.17, Low D/E 3.0%, current ratio 2.98x
- Beta 2.17, current ratio 2.98x
- Lower P/E (31.4x vs 59.2x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.6% revenue growth vs AZTA's -9.5% | |
| Value | Lower P/E (31.4x vs 59.2x) | |
| Quality / Margins | -5.3% margin vs AZTA's -10.3% | |
| Stability / Safety | Beta 2.17 vs ICHR's 3.93, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +225.2% vs AZTA's -6.1% | |
| Efficiency (ROA) | -3.0% ROA vs ICHR's -5.2%, ROIC -0.6% vs -3.9% |
ICHR vs AZTA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ICHR vs AZTA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — ICHR and AZTA each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ICHR is the larger business by revenue, generating $959M annually — 1.6x AZTA's $595M. ICHR is the more profitable business, keeping -5.3% of every revenue dollar as net income compared to AZTA's -10.3%. On growth, ICHR holds the edge at +4.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $959M | $595M |
| EBITDAEarnings before interest/tax | -$11M | $24M |
| Net IncomeAfter-tax profit | -$51M | -$62M |
| Free Cash FlowCash after capex | -$17M | $31M |
| Gross MarginGross profit ÷ Revenue | +11.3% | +44.6% |
| Operating MarginEBIT ÷ Revenue | -3.8% | -3.2% |
| Net MarginNet income ÷ Revenue | -5.3% | -10.3% |
| FCF MarginFCF ÷ Revenue | -1.7% | +5.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.7% | +0.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +46.2% | -17.2% |
Valuation Metrics
AZTA leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.4B | $1.1B |
| Enterprise ValueMkt cap + debt − cash | $2.4B | $900M |
| Trailing P/EPrice ÷ TTM EPS | -44.01x | -18.93x |
| Forward P/EPrice ÷ next-FY EPS est. | 59.22x | 31.38x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 18.02x |
| Price / SalesMarket cap ÷ Revenue | 2.48x | 1.90x |
| Price / BookPrice ÷ Book value/share | 3.49x | 0.65x |
| Price / FCFMarket cap ÷ FCF | — | 29.45x |
Profitability & Efficiency
AZTA leads this category, winning 8 of 8 comparable metrics.
Profitability & Efficiency
AZTA delivers a -3.6% return on equity — every $100 of shareholder capital generates $-4 in annual profit, vs $-8 for ICHR. AZTA carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to ICHR's 0.28x. On the Piotroski fundamental quality scale (0–9), AZTA scores 6/9 vs ICHR's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -7.5% | -3.6% |
| ROA (TTM)Return on assets | -5.2% | -3.0% |
| ROICReturn on invested capital | -3.9% | -0.6% |
| ROCEReturn on capital employed | -4.7% | -0.6% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 |
| Debt / EquityFinancial leverage | 0.28x | 0.03x |
| Net DebtTotal debt minus cash | $87M | -$229M |
| Cash & Equiv.Liquid assets | $98M | $280M |
| Total DebtShort + long-term debt | $186M | $51M |
| Interest CoverageEBIT ÷ Interest expense | -5.97x | — |
Total Returns (Dividends Reinvested)
ICHR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ICHR five years ago would be worth $12,419 today (with dividends reinvested), compared to $2,630 for AZTA. Over the past 12 months, ICHR leads with a +225.2% total return vs AZTA's -6.1%. The 3-year compound annual growth rate (CAGR) favors ICHR at 33.5% vs AZTA's -18.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +232.0% | -26.3% |
| 1-Year ReturnPast 12 months | +225.2% | -6.1% |
| 3-Year ReturnCumulative with dividends | +137.9% | -46.0% |
| 5-Year ReturnCumulative with dividends | +24.2% | -73.7% |
| 10-Year ReturnCumulative with dividends | +593.7% | +185.4% |
| CAGR (3Y)Annualised 3-year return | +33.5% | -18.6% |
Risk & Volatility
Evenly matched — ICHR and AZTA each lead in 1 of 2 comparable metrics.
Risk & Volatility
AZTA is the less volatile stock with a 2.17 beta — it tends to amplify market swings less than ICHR's 3.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ICHR currently trades 93.0% from its 52-week high vs AZTA's 59.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.93x | 2.17x |
| 52-Week HighHighest price in past year | $72.87 | $41.73 |
| 52-Week LowLowest price in past year | $13.12 | $19.87 |
| % of 52W HighCurrent price vs 52-week peak | +93.0% | +59.0% |
| RSI (14)Momentum oscillator 0–100 | 65.5 | 50.3 |
| Avg Volume (50D)Average daily shares traded | 793K | 871K |
Analyst Outlook
ICHR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates ICHR as "Buy" and AZTA as "Buy". Consensus price targets imply 81.5% upside for AZTA (target: $45) vs -26.5% for ICHR (target: $50).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $49.80 | $44.67 |
| # AnalystsCovering analysts | 14 | 12 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 1 | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
AZTA leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). ICHR leads in 2 (Total Returns, Analyst Outlook). 2 tied.
ICHR vs AZTA: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is ICHR or AZTA a better buy right now?
For growth investors, Ichor Holdings, Ltd.
(ICHR) is the stronger pick with 11. 6% revenue growth year-over-year, versus -9. 5% for Azenta, Inc. (AZTA). Analysts rate Ichor Holdings, Ltd. (ICHR) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ICHR or AZTA?
Over the past 5 years, Ichor Holdings, Ltd.
(ICHR) delivered a total return of +24. 2%, compared to -73. 7% for Azenta, Inc. (AZTA). Over 10 years, the gap is even starker: ICHR returned +593. 7% versus AZTA's +185. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ICHR or AZTA?
By beta (market sensitivity over 5 years), Azenta, Inc.
(AZTA) is the lower-risk stock at 2. 17β versus Ichor Holdings, Ltd. 's 3. 93β — meaning ICHR is approximately 81% more volatile than AZTA relative to the S&P 500. On balance sheet safety, Azenta, Inc. (AZTA) carries a lower debt/equity ratio of 3% versus 28% for Ichor Holdings, Ltd. — giving it more financial flexibility in a downturn.
04Which is growing faster — ICHR or AZTA?
By revenue growth (latest reported year), Ichor Holdings, Ltd.
(ICHR) is pulling ahead at 11. 6% versus -9. 5% for Azenta, Inc. (AZTA). On earnings-per-share growth, the picture is similar: Azenta, Inc. grew EPS 57. 9% year-over-year, compared to -140. 6% for Ichor Holdings, Ltd.. Over a 3-year CAGR, AZTA leads at 2. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ICHR or AZTA?
Ichor Holdings, Ltd.
(ICHR) is the more profitable company, earning -5. 6% net margin versus -10. 0% for Azenta, Inc. — meaning it keeps -5. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AZTA leads at -1. 9% versus -4. 1% for ICHR. At the gross margin level — before operating expenses — AZTA leads at 45. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is ICHR or AZTA more undervalued right now?
On forward earnings alone, Azenta, Inc.
(AZTA) trades at 31. 4x forward P/E versus 59. 2x for Ichor Holdings, Ltd. — 27. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AZTA: 81. 5% to $44. 67.
07Which pays a better dividend — ICHR or AZTA?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is ICHR or AZTA better for a retirement portfolio?
For long-horizon retirement investors, Ichor Holdings, Ltd.
(ICHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+593. 7% 10Y return). Azenta, Inc. (AZTA) carries a higher beta of 2. 17 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ICHR: +593. 7%, AZTA: +185. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ICHR and AZTA?
These companies operate in different sectors (ICHR (Technology) and AZTA (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.